Elaine Kulm

Statistics

Publications

Citations

355

H-Index

Active since

2010

Affiliations

National Institutes of Health(Current)

Frederick National Laboratory for Cancer Research

National Institute of Allergy and Infectious Diseases

Erasmus MC

Charles University

Elaine Kulm is an author at National Institutes of Health specializing in pi3k signaling, phosphoinositide 3-kinase signaling, and clinical pharmacology.

Publications per year

2010–2024

Publications

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

V. Koneti Rao, Sharon Webster, Anna Šedivá et al. · Blood · 2022 · 132 citations · Full text

Medicine, Immunology, Pharmacology +13

Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function

Jahnavi Aluri, Alicia Bach, Saara Kaviany et al. · Blood · 2020 · 103 citations · Full text

Life Sciences, Genetics, Immunology +16

Palliative and End-of-Life Care in the Emergency Department: Guidelines for Nurses

Colleen Norton, Gwen Hobson, Elaine Kulm · Journal of Emergency Nursing · 2010 · 40 citations

Nursing, Hospice Nursing, Palliative Nursing +14

Interim analysis: Open-label extension study of leniolisib for patients with APDS

V. Koneti Rao, Elaine Kulm, Anna Šedivá et al. · Journal of Allergy and Clinical Immunology · 2023 · 40 citations · Full text

Medicine, Immunology, Pharmacology +15

Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome

V. Koneti Rao, Elaine Kulm, Jennifer Grossman et al. · Blood Advances · 2024 · 15 citations · Full text

Life Sciences, Immunology, Pharmacology +14

1–5 of 7